In a draft study, researchers correlated cellphone data showing students' back-to-campus movements and county infection rates to quantify how the coronavirus spread as colleges and universities reopened for the fall semester.
If the executive branch were to overrule the FDA’s scientific judgment, a vaccine of limited efficacy and, worse, unknown side effects could be rushed to market.